Table 2 Clinical and genetic data
Characteristic | Poor ovarian response (n = 36) | Controls (n = 98) |
|---|---|---|
Age mean (95% CI) | 34.0b (32.8-35.3) | 32.4 (31.9-32.8) |
BMI (kg/m 2 ) mean (95% CI) | 26.5b (24.3-28.7) | 23.8 (23.1-24.5) |
No. of patients of other ethnicities than Caucasian (%) | 3 (8.3) | 4 (4.1) |
First time COH (%) | 32 (88.9) | 83 (84.7) |
Early follicular phase s-FSH a mean (95% CI) | 6.0 (5.3-6.7) | 5.8 (5.4-6.3) |
First dose of rFSH (IU) mean (95% CI) | 160 (152–168) | 159 (155–162) |
Duration of rFSH medication (Days) mean (95% CI) | 10.8 (10.2-11.3) | 10.9 (10.8-11.1) |
Total dose of rFSH (IU) mean (95% CI) | 1739 (1616–1863) | 1738 (1692–1784) |
Oocytes retrieved mean (95% CI) | 1.5b (1.1-2.0) | 9.0 (8.5-9.5) |
No. of embryos transferred mean (95% CI) | 0.6b (0.4-0.9) | 1.6 (1.5-1.7) |
Live births (% of started COH) | 2b (6) | 45 (46) |
No. of patients with v-betaLH (%) | 4 (11) | 17 (17) |
No. of alleles with v-betaLH (%) | 4 (6) | 18 (9) |